Cryo-Cell International, Inc.
CCEL
$3.10
$0.165.44%
AMEX
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.23% | -1.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.23% | -1.30% | |||
| Cost of Revenue | 238.23% | -2.97% | |||
| Gross Profit | -70.95% | -0.80% | |||
| SG&A Expenses | 40.56% | -8.96% | |||
| Depreciation & Amortization | -1.02% | -2.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 99.33% | -7.94% | |||
| Operating Income | -308.72% | 27.33% | |||
| Income Before Tax | -490.56% | 106.23% | |||
| Income Tax Expenses | -286.56% | 99.09% | |||
| Earnings from Continuing Operations | -609.39% | 110.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -609.39% | 110.62% | |||
| EBIT | -308.72% | 27.33% | |||
| EBITDA | -273.64% | 23.05% | |||
| EPS Basic | -609.57% | 111.36% | |||
| Normalized Basic EPS | -421.21% | 44.99% | |||
| EPS Diluted | -626.56% | 125.00% | |||
| Normalized Diluted EPS | -421.82% | 45.50% | |||
| Average Basic Shares Outstanding | -0.03% | -0.28% | |||
| Average Diluted Shares Outstanding | -0.23% | -0.64% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | -- | -1.00% | |||